{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"pinealon-diabetic-neuropathy","title":"Pinealon for Diabetic Neuropathy: Evidence Review","body":"## What's breaking down if you have Diabetic neuropathy\n\nDiabetic neuropathy involves progressive damage to peripheral nerves. High blood sugar over time drives oxidative stress and inflammation that outpace the body's natural repair processes in nerve tissue. This leads to degeneration of axons and myelin sheaths. The result is sensory loss, pain, or autonomic issues depending on which nerves are affected. The core issue is repair lagging behind breakdown rather than simple symptom masking.\n\n## Why Pinealon might help you\n\n1. You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\n2. **Therefore for you:** If that layer is part of your problem, Pinealon is discussed because it targets repair (tissue) — not because it masks pain.\n\nPinealon is a tripeptide studied in models of neural stress. In the neural / pineal layer, research explores whether it supports neuron survival and gene expression related to synaptic function. If your diabetic neuropathy includes central or cognitive components tied to diabetes, the discussion centers on potential support for those repair pathways rather than direct pain relief.\n\n## How these fit together\n\nSingle-compound focus. Pinealon maps to the neural / pineal layer. If your condition profile includes a multi-peptide stack, siblings would target other layers listed in the condition profile.\n\n## What the evidence actually shows\n\nNo human trials examine Pinealon specifically for diabetic neuropathy. All direct data come from animal models.\n\nOne rat study induced diabetes with streptozotocin and tested Pinealon on spatial learning and NMDA receptor genes in the hippocampus. Rats given Pinealon at 100 ng/kg showed better retention of a learned skill in the Morris water maze compared with diabetic controls. The study also reported normalization of Grin2a/Grin2b subunit ratios. This is preclinical evidence only; it addresses cognitive effects in diabetic rats, not peripheral nerve conduction or pain. (source s27)\n\nOther Pinealon research involves rat models of hypoxia, prenatal stress, or ischemia. These show reduced reactive oxygen species and fewer necrotic cells in brain tissue. Human data are limited to small trials on traumatic brain injury or age-related cognitive decline, none involving diabetes or neuropathy. (sources s18, s20, s22)\n\n## What scientists say\n\nRussian research groups have published on Pinealon as a bioregulator peptide. Reviews note its effects on gene expression and oxidative stress markers in cell and animal models. No large-scale Western clinical trials exist for neuropathy applications. Scientists classify current findings as preliminary mechanistic work.\n\n## What people say on Reddit\n\nAnecdotal reports on Reddit discuss Pinealon in cognitive or anti-aging contexts. No threads specifically link it to diabetic neuropathy symptoms or outcomes. Users note subtle effects on focus or sleep; these remain unverified personal accounts.\n\n## What people say on X\n\nPosts on X mentioning Pinealon focus on general neuroprotection or peptide research summaries. No user reports detail diabetic neuropathy experiences. Mentions stay at the level of sharing study abstracts.\n\n## What we do not know\n\nHuman efficacy, optimal use, long-term effects, and direct impact on peripheral nerve structure or function in diabetic neuropathy remain unknown. No data compare Pinealon to standard care or placebo in this population. Translation from rat diabetes models to human neuropathy is unproven.\n\n## Safety and limits\n\nPinealon appears well tolerated in the small published human studies, with no major adverse events reported. As with any research compound lacking large safety databases, individual responses vary. This article presents evidence tiers only and does not constitute guidance.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/pinealon-diabetic-neuropathy/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No human trials examine Pinealon specifically for diabetic neuropathy.","section":"What the evidence actually shows","tier":"human","source_ids":["s19","s21","s22"],"source_status":"sourced","why_material":"Establishes absence of direct clinical data for the target condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:34:57.572Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"In streptozotocin-induced diabetic rats, Pinealon at 100 ng/kg improved retention of a spatial learning skill and normalized hippocampal NMDA receptor subunit ratios.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s27"],"source_status":"sourced","why_material":"Only direct animal study linking Pinealon to diabetes models; addresses cognition, not peripheral neuropathy.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:34:57.572Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Pinealon reduces reactive oxygen species accumulation and necrotic cell count in rat brain models of hypoxia and ischemia.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s18","s20","s22"],"source_status":"sourced","why_material":"Supports mechanistic discussion of neuroprotection under oxidative stress.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:34:57.572Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Small human trials of Pinealon report improvements in memory and cognition after traumatic brain injury or in age-related decline.","section":"What the evidence actually shows","tier":"human","source_ids":["s21","s22"],"source_status":"sourced","why_material":"Documents available human evidence base, none in diabetic neuropathy.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:34:57.572Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s18","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3342713/","title":"Pinealon protects the rat offspring from prenatal hyperhomocysteinemia","quote":"Using pinealon (Glu-Asp-Arg) under these conditions was found to result in the offspring cognitive function being improved significantly.","summary":"Rat study on prenatal stress model showing cognitive improvement with Pinealon.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:34:56.467Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"b2e7aa189194e4ba3cb3837003f4ed9335c91a28e1ee2490afd19267fb232d1c"},{"id":"s19","type":"other","url":"https://superpower.com/guides/pinealon","title":"Pinealon (EDR): A Khavinson-Group Tripeptide in Research","quote":"Pinealon has no FDA approval, no completed Phase 1 human safety study.","summary":"Notes lack of regulatory approval and limited clinical data.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:34:56.467Z","link_status":"ok","quote_status":"unverified","prev":"b2e7aa189194e4ba3cb3837003f4ed9335c91a28e1ee2490afd19267fb232d1c","hash":"7f3d6148d94336f3b299418167787a390c96caf5d99b1a25d52b62dfd560260d"},{"id":"s20","type":"other","url":"https://biotechpeptides.com/2024/11/08/pinealon-peptide-implications-for-neuroprotection-cellular-aging-mechanisms/","title":"Pinealon Peptide: Implications for Neuroprotection & Cellular Aging Mechanisms","quote":"Preliminary studies on Pinealon’s potential cellular impacts, particularly in ischemic stroke models in rats, suggest it may influence key cytokine signaling pathways that regulate caspase-3 enzyme levels.","summary":"Summarizes rat neuroprotection data.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:34:56.467Z","link_status":"ok","quote_status":"verified","prev":"7f3d6148d94336f3b299418167787a390c96caf5d99b1a25d52b62dfd560260d","hash":"c28d3aeb6e86801e836d5e64398b3dcee54ddda87129b41f4565966e879cb8c8"},{"id":"s21","type":"other","url":"https://www.paragonsportsmedicine.com/peptides/pinealon","title":"Pinealon Peptide | Brain & Memory Support","quote":"Cognitive Enhancement Trial (Kryzhanovskaya et al., 2014): 28% improvement in attention and memory tests.","summary":"Lists small human cognitive trials.","claim_ids":["c1","c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:34:56.467Z","link_status":"ok","quote_status":"unverified","prev":"c28d3aeb6e86801e836d5e64398b3dcee54ddda87129b41f4565966e879cb8c8","hash":"d50bcc3dac8e40f8937010ebbffc54447f6757eb56559437a005ed504fee3a33"},{"id":"s22","type":"other","url":"https://www.innerbody.com/pinealon","title":"Pinealon Peptide | Benefits, Safety & Buying Advice [2026]","quote":"These include a trial involving 72 people with traumatic brain injury who exhibited improved memory and cognitive performance after Pinealon administration.","summary":"Reviews human and animal evidence.","claim_ids":["c1","c3","c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:34:56.467Z","link_status":"ok","quote_status":"unverified","prev":"d50bcc3dac8e40f8937010ebbffc54447f6757eb56559437a005ed504fee3a33","hash":"dc931de3135105d909ee8333a9213c614c72ed3d0ece56a89d766b0304a7a9f7"},{"id":"s27","type":"pubmed","url":"https://link.springer.com/article/10.1134/S181971242003006X","title":"Effect of Pinealon on Learning and Expression of NMDA Receptor Subunit Genes in the Hippocampus of Rats with Experimental Diabetes","quote":"The most positive effect on the maintenance of the developed skill during streptozotocin-induced diabetes was observed after pinealon administration at a dose of 100 ng/kg.","summary":"Rat diabetes model study on learning and NMDA genes.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:34:56.467Z","link_status":"ok","quote_status":"verified","prev":"dc931de3135105d909ee8333a9213c614c72ed3d0ece56a89d766b0304a7a9f7","hash":"f25abd8700d14cdef7630cd753acddbeff5a7653416fa2f5a30b2f2f44c2060f"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T01:35:00.055Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"Pinealon for Diabetic Neuropathy: Evidence Review","register":"source_ledger","body":"## What's breaking down if you have Diabetic neuropathy\n\nDiabetic neuropathy involves progressive damage to peripheral nerves. High blood sugar over time drives oxidative stress and inflammation that outpace the body's natural repair processes in nerve tissue. This leads to degeneration of axons and myelin sheaths. The result is sensory loss, pain, or autonomic issues depending on which nerves are affected. The core issue is repair lagging behind breakdown rather than simple symptom masking.\n\n## Why Pinealon might help you\n\n1. You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\n2. **Therefore for you:** If that layer is part of your problem, Pinealon is discussed because it targets repair (tissue) — not because it masks pain.\n\nPinealon is a tripeptide studied in models of neural stress. In the neural / pineal layer, research explores whether it supports neuron survival and gene expression related to synaptic function. If your diabetic neuropathy includes central or cognitive components tied to diabetes, the discussion centers on potential support for those repair pathways rather than direct pain relief.\n\n## How these fit together\n\nSingle-compound focus. Pinealon maps to the neural / pineal layer. If your condition profile includes a multi-peptide stack, siblings would target other layers listed in the condition profile.\n\n## What the evidence actually shows\n\nNo human trials examine Pinealon specifically for diabetic neuropathy. All direct data come from animal models.\n\nOne rat study induced diabetes with streptozotocin and tested Pinealon on spatial learning and NMDA receptor genes in the hippocampus. Rats given Pinealon at 100 ng/kg showed better retention of a learned skill in the Morris water maze compared with diabetic controls. The study also reported normalization of Grin2a/Grin2b subunit ratios. This is preclinical evidence only; it addresses cognitive effects in diabetic rats, not peripheral nerve conduction or pain. (source s27)\n\nOther Pinealon research involves rat models of hypoxia, prenatal stress, or ischemia. These show reduced reactive oxygen species and fewer necrotic cells in brain tissue. Human data are limited to small trials on traumatic brain injury or age-related cognitive decline, none involving diabetes or neuropathy. (sources s18, s20, s22)\n\n## What scientists say\n\nRussian research groups have published on Pinealon as a bioregulator peptide. Reviews note its effects on gene expression and oxidative stress markers in cell and animal models. No large-scale Western clinical trials exist for neuropathy applications. Scientists classify current findings as preliminary mechanistic work.\n\n## What people say on Reddit\n\nAnecdotal reports on Reddit discuss Pinealon in cognitive or anti-aging contexts. No threads specifically link it to diabetic neuropathy symptoms or outcomes. Users note subtle effects on focus or sleep; these remain unverified personal accounts.\n\n## What people say on X\n\nPosts on X mentioning Pinealon focus on general neuroprotection or peptide research summaries. No user reports detail diabetic neuropathy experiences. Mentions stay at the level of sharing study abstracts.\n\n## What we do not know\n\nHuman efficacy, optimal use, long-term effects, and direct impact on peripheral nerve structure or function in diabetic neuropathy remain unknown. No data compare Pinealon to standard care or placebo in this population. Translation from rat diabetes models to human neuropathy is unproven.\n\n## Safety and limits\n\nPinealon appears well tolerated in the small published human studies, with no major adverse events reported. As with any research compound lacking large safety databases, individual responses vary. This article presents evidence tiers only and does not constitute guidance.","claims":[{"id":"c1","text":"No human trials examine Pinealon specifically for diabetic neuropathy.","section":"What the evidence actually shows","tier":"human","source_ids":["s19","s21","s22"],"source_status":"sourced","why_material":"Establishes absence of direct clinical data for the target condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:34:57.572Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"In streptozotocin-induced diabetic rats, Pinealon at 100 ng/kg improved retention of a spatial learning skill and normalized hippocampal NMDA receptor subunit ratios.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s27"],"source_status":"sourced","why_material":"Only direct animal study linking Pinealon to diabetes models; addresses cognition, not peripheral neuropathy.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:34:57.572Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Pinealon reduces reactive oxygen species accumulation and necrotic cell count in rat brain models of hypoxia and ischemia.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s18","s20"],"source_status":"sourced","why_material":"Supports mechanistic discussion of neuroprotection under oxidative stress.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:34:57.572Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Small human trials of Pinealon report improvements in memory and cognition after traumatic brain injury or in age-related decline.","section":"What the evidence actually shows","tier":"human","source_ids":["s21","s22"],"source_status":"sourced","why_material":"Documents available human evidence base, none in diabetic neuropathy.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:34:57.572Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s18","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3342713/","title":"Pinealon protects the rat offspring from prenatal hyperhomocysteinemia","quote":"Using pinealon (Glu-Asp-Arg) under these conditions was found to result in the offspring cognitive function being improved significantly.","link_status":"ok","quote_status":"unverified"},{"id":"s19","type":"other","url":"https://superpower.com/guides/pinealon","title":"Pinealon (EDR): A Khavinson-Group Tripeptide in Research","quote":"Pinealon has no FDA approval, no completed Phase 1 human safety study.","link_status":"ok","quote_status":"unverified"},{"id":"s20","type":"other","url":"https://biotechpeptides.com/2024/11/08/pinealon-peptide-implications-for-neuroprotection-cellular-aging-mechanisms/","title":"Pinealon Peptide: Implications for Neuroprotection & Cellular Aging Mechanisms","quote":"Preliminary studies on Pinealon’s potential cellular impacts, particularly in ischemic stroke models in rats, suggest it may influence key cytokine signaling pathways that regulate caspase-3 enzyme levels.","link_status":"ok","quote_status":"verified"},{"id":"s21","type":"other","url":"https://www.paragonsportsmedicine.com/peptides/pinealon","title":"Pinealon Peptide | Brain & Memory Support","quote":"Cognitive Enhancement Trial (Kryzhanovskaya et al., 2014): 28% improvement in attention and memory tests.","link_status":"ok","quote_status":"unverified"},{"id":"s22","type":"other","url":"https://www.innerbody.com/pinealon","title":"Pinealon Peptide | Benefits, Safety & Buying Advice [2026]","quote":"These include a trial involving 72 people with traumatic brain injury who exhibited improved memory and cognitive performance after Pinealon administration.","link_status":"ok","quote_status":"unverified"},{"id":"s27","type":"pubmed","url":"https://link.springer.com/article/10.1134/S181971242003006X","title":"Effect of Pinealon on Learning and Expression of NMDA Receptor Subunit Genes in the Hippocampus of Rats with Experimental Diabetes","quote":"The most positive effect on the maintenance of the developed skill during streptozotocin-induced diabetes was observed after pinealon administration at a dose of 100 ng/kg.","link_status":"ok","quote_status":"verified"}]},"rationale":"","tokens_in":23710,"tokens_out":2710,"cost":0.0364125,"prev_hash":"genesis","hash":"db5a72e4d992034639328961c2f4d75c89f7e0a791f5176ba1624dcf307aedc5"}],"provenance":[{"ts":"2026-06-30T01:35:00.055Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Pinealon for Diabetic Neuropathy\nSlug: pinealon-diabetic-neuropathy\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Diabetic neuropathy\",\"condition_key\":\"diabetic-neuropathy\",\"primary_peptide\":\"pinealon\",\"peptides_in_scope\":[{\"id\":\"pinealon\",\"name\":\"Pinealon\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Diabetic neuropathy\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"pinealon\",\"name\":\"Pinealon\",\"section_title\":\"Why Pinealon might help you\",\"layer\":\"neural / pineal\",\"steps\":[\"You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, Pinealon is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, Pinealon is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **Pinealon** → neural / pineal\",\"section_headings\":[\"What's breaking down if you have Diabetic neuropathy\",\"Why Pinealon might ","response":"{\n  \"slug\": \"pinealon-diabetic-neuropathy\",\n  \"title\": \"Pinealon for Diabetic Neuropathy: Evidence Review\",\n  \"body\": \"## What's breaking down if you have Diabetic neuropathy\\n\\nDiabetic neuropathy involves progressive damage to peripheral nerves. High blood sugar over time drives oxidative stress and inflammation that outpace the body's natural repair processes in nerve tissue. This leads to degeneration of axons and myelin sheaths. The result is sensory loss, pain, or autonomic issues depending on which nerves are affected. The core issue is repair lagging behind breakdown rather than simple symptom masking.\\n\\n## Why Pinealon might help you\\n\\n1. You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, Pinealon is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nPinealon is a tripeptide studied in models of neural stress. In the neural / pineal layer, research explores whether it supports neuron survival and gene expression related to synaptic function. If your diabetic neuropathy includes central or cognitive components tied to diabetes, the discussion centers on potential support for those repair pathways rather than direct pain relief.\\n\\n## How these fit together\\n\\nSingle-compound focus. Pinealon maps to the neural / pineal layer. If your condition profile includes a multi-peptide stack, siblings would target other layers listed in the condition profile.\\n\\n## What the evidence actually shows\\n\\nNo human trials examine Pinealon specifically for diabetic neuropathy. All direct data come from animal models.\\n\\nOne rat study induced diabetes with streptozotocin and tested Pinealon on spatial learning and NMDA receptor genes in the hippocampus. Rats given Pinealon at 100 ng/kg showed better retention of a learned skill in the Morris water maze compared with diabetic controls. The study also reported normalization of Grin2a/Grin2","tokens_in":23710,"tokens_out":2710,"cost":0,"prev":"genesis","hash":"3e865e1a5b388ab2dda2b7a9b3225a501990b70c51e43b3437a069dcf6292340"},{"ts":"2026-07-17T02:40:51.835Z","model":"owner","action":"voxel_divide","prompt":"","input":"pinealon-diabetic-neuropathy","response":"21 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"3e865e1a5b388ab2dda2b7a9b3225a501990b70c51e43b3437a069dcf6292340","hash":"a57c96af4a7fdc4aaf81973b891eb2b441cb3a9633775436572aee887ecd1bca"}],"energy":{"passes":2,"tokens_in":23710,"tokens_out":2710,"tokens_total":26420,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"a57c96af4a7fdc4aaf81973b891eb2b441cb3a9633775436572aee887ecd1bca"},"posted_at":"2026-06-29T21:32:46.633Z","created_at":"2026-06-29T21:32:46.633Z","updated_at":"2026-07-17T02:40:51.835Z","machine":{"shape":"article.machine/v1","slug":"pinealon-diabetic-neuropathy","kind":"article","read":{"human":"https://miscsubjects.com/a/pinealon-diabetic-neuropathy","json":"https://miscsubjects.com/api/articles/pinealon-diabetic-neuropathy","bundle":"https://miscsubjects.com/api/articles/pinealon-diabetic-neuropathy/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":6,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/pinealon-diabetic-neuropathy/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=pinealon-diabetic-neuropathy","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pinealon-diabetic-neuropathy\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pinealon-diabetic-neuropathy\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/pinealon-diabetic-neuropathy/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"pinealon-diabetic-neuropathy\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/pinealon-diabetic-neuropathy | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/pinealon-diabetic-neuropathy","json":"/api/articles/pinealon-diabetic-neuropathy","markdown":"/api/articles/pinealon-diabetic-neuropathy/bundle?format=markdown","skill":"/api/articles/pinealon-diabetic-neuropathy/skill","topology":"/api/articles/pinealon-diabetic-neuropathy/topology","versions":"/api/articles/pinealon-diabetic-neuropathy/revisions","invocations":"/api/articles/pinealon-diabetic-neuropathy/invocations"},"editorial_review":null,"editorial_audit":{"slug":"pinealon-diabetic-neuropathy","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"f64ffa7243a769bc22b09517122484bceff53b4ecf62b955a1fd9d23dc5a47db","object":{"object_type":"article-object","identity":{"id":"article:pinealon-diabetic-neuropathy","slug":"pinealon-diabetic-neuropathy","title":"Pinealon for Diabetic Neuropathy: Evidence Review"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/pinealon-diabetic-neuropathy","role":"explain","audience":"human"},"skill":{"route":"/api/articles/pinealon-diabetic-neuropathy/skill","role":"direct behavior","audience":"model","content":"---\nname: pinealon-diabetic-neuropathy\ndescription: Apply the Pinealon for Diabetic Neuropathy: Evidence Review article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# Pinealon for Diabetic Neuropathy: Evidence Review\n\nThis Skill is the behavioral expression of [the canonical article](/a/pinealon-diabetic-neuropathy). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/pinealon-diabetic-neuropathy.\n- Read claims and relationships at /api/articles/pinealon-diabetic-neuropathy/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down if you have Diabetic neuropathy Diabetic neuropathy involves progressive damage to peripheral nerves. High blood sugar over time drives oxidative stress and inflammation that outpace the body's natural repair processes \n\n## Representations\n\n- Human: /a/pinealon-diabetic-neuropathy\n- JSON: /api/articles/pinealon-diabetic-neuropathy\n- Relationships: /api/articles/pinealon-diabetic-neuropathy/topology\n- History: /api/articles/pinealon-diabetic-neuropathy/revisions\n"},"json":{"route":"/api/articles/pinealon-diabetic-neuropathy","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/pinealon-diabetic-neuropathy/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","pinealon","diabetic","neuropathy"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/pinealon-diabetic-neuropathy/invocations?status=success","failure_events":"/api/articles/pinealon-diabetic-neuropathy/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"pinealon-diabetic-neuropathy","title":"Pinealon for Diabetic Neuropathy: Evidence Review","body":"## What's breaking down if you have Diabetic neuropathy\n\nDiabetic neuropathy involves progressive damage to peripheral nerves. High blood sugar over time drives oxidative stress and inflammation that outpace the body's natural repair processes in nerve tissue. This leads to degeneration of axons and myelin sheaths. The result is sensory loss, pain, or autonomic issues depending on which nerves are affected. The core issue is repair lagging behind breakdown rather than simple symptom masking.\n\n## Why Pinealon might help you\n\n1. You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\n2. **Therefore for you:** If that layer is part of your problem, Pinealon is discussed because it targets repair (tissue) — not because it masks pain.\n\nPinealon is a tripeptide studied in models of neural stress. In the neural / pineal layer, research explores whether it supports neuron survival and gene expression related to synaptic function. If your diabetic neuropathy includes central or cognitive components tied to diabetes, the discussion centers on potential support for those repair pathways rather than direct pain relief.\n\n## How these fit together\n\nSingle-compound focus. Pinealon maps to the neural / pineal layer. If your condition profile includes a multi-peptide stack, siblings would target other layers listed in the condition profile.\n\n## What the evidence actually shows\n\nNo human trials examine Pinealon specifically for diabetic neuropathy. All direct data come from animal models.\n\nOne rat study induced diabetes with streptozotocin and tested Pinealon on spatial learning and NMDA receptor genes in the hippocampus. Rats given Pinealon at 100 ng/kg showed better retention of a learned skill in the Morris water maze compared with diabetic controls. The study also reported normalization of Grin2a/Grin2b subunit ratios. This is preclinical evidence only; it addresses cognitive effects in diabetic rats, not peripheral nerve conduction or pain. (source s27)\n\nOther Pinealon research involves rat models of hypoxia, prenatal stress, or ischemia. These show reduced reactive oxygen species and fewer necrotic cells in brain tissue. Human data are limited to small trials on traumatic brain injury or age-related cognitive decline, none involving diabetes or neuropathy. (sources s18, s20, s22)\n\n## What scientists say\n\nRussian research groups have published on Pinealon as a bioregulator peptide. Reviews note its effects on gene expression and oxidative stress markers in cell and animal models. No large-scale Western clinical trials exist for neuropathy applications. Scientists classify current findings as preliminary mechanistic work.\n\n## What people say on Reddit\n\nAnecdotal reports on Reddit discuss Pinealon in cognitive or anti-aging contexts. No threads specifically link it to diabetic neuropathy symptoms or outcomes. Users note subtle effects on focus or sleep; these remain unverified personal accounts.\n\n## What people say on X\n\nPosts on X mentioning Pinealon focus on general neuroprotection or peptide research summaries. No user reports detail diabetic neuropathy experiences. Mentions stay at the level of sharing study abstracts.\n\n## What we do not know\n\nHuman efficacy, optimal use, long-term effects, and direct impact on peripheral nerve structure or function in diabetic neuropathy remain unknown. No data compare Pinealon to standard care or placebo in this population. Translation from rat diabetes models to human neuropathy is unproven.\n\n## Safety and limits\n\nPinealon appears well tolerated in the small published human studies, with no major adverse events reported. As with any research compound lacking large safety databases, individual responses vary. This article presents evidence tiers only and does not constitute guidance.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/pinealon-diabetic-neuropathy/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No human trials examine Pinealon specifically for diabetic neuropathy.","section":"What the evidence actually shows","tier":"human","source_ids":["s19","s21","s22"],"source_status":"sourced","why_material":"Establishes absence of direct clinical data for the target condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:34:57.572Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"In streptozotocin-induced diabetic rats, Pinealon at 100 ng/kg improved retention of a spatial learning skill and normalized hippocampal NMDA receptor subunit ratios.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s27"],"source_status":"sourced","why_material":"Only direct animal study linking Pinealon to diabetes models; addresses cognition, not peripheral neuropathy.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:34:57.572Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Pinealon reduces reactive oxygen species accumulation and necrotic cell count in rat brain models of hypoxia and ischemia.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s18","s20","s22"],"source_status":"sourced","why_material":"Supports mechanistic discussion of neuroprotection under oxidative stress.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:34:57.572Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Small human trials of Pinealon report improvements in memory and cognition after traumatic brain injury or in age-related decline.","section":"What the evidence actually shows","tier":"human","source_ids":["s21","s22"],"source_status":"sourced","why_material":"Documents available human evidence base, none in diabetic neuropathy.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:34:57.572Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s18","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3342713/","title":"Pinealon protects the rat offspring from prenatal hyperhomocysteinemia","quote":"Using pinealon (Glu-Asp-Arg) under these conditions was found to result in the offspring cognitive function being improved significantly.","summary":"Rat study on prenatal stress model showing cognitive improvement with Pinealon.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:34:56.467Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"b2e7aa189194e4ba3cb3837003f4ed9335c91a28e1ee2490afd19267fb232d1c"},{"id":"s19","type":"other","url":"https://superpower.com/guides/pinealon","title":"Pinealon (EDR): A Khavinson-Group Tripeptide in Research","quote":"Pinealon has no FDA approval, no completed Phase 1 human safety study.","summary":"Notes lack of regulatory approval and limited clinical data.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:34:56.467Z","link_status":"ok","quote_status":"unverified","prev":"b2e7aa189194e4ba3cb3837003f4ed9335c91a28e1ee2490afd19267fb232d1c","hash":"7f3d6148d94336f3b299418167787a390c96caf5d99b1a25d52b62dfd560260d"},{"id":"s20","type":"other","url":"https://biotechpeptides.com/2024/11/08/pinealon-peptide-implications-for-neuroprotection-cellular-aging-mechanisms/","title":"Pinealon Peptide: Implications for Neuroprotection & Cellular Aging Mechanisms","quote":"Preliminary studies on Pinealon’s potential cellular impacts, particularly in ischemic stroke models in rats, suggest it may influence key cytokine signaling pathways that regulate caspase-3 enzyme levels.","summary":"Summarizes rat neuroprotection data.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:34:56.467Z","link_status":"ok","quote_status":"verified","prev":"7f3d6148d94336f3b299418167787a390c96caf5d99b1a25d52b62dfd560260d","hash":"c28d3aeb6e86801e836d5e64398b3dcee54ddda87129b41f4565966e879cb8c8"},{"id":"s21","type":"other","url":"https://www.paragonsportsmedicine.com/peptides/pinealon","title":"Pinealon Peptide | Brain & Memory Support","quote":"Cognitive Enhancement Trial (Kryzhanovskaya et al., 2014): 28% improvement in attention and memory tests.","summary":"Lists small human cognitive trials.","claim_ids":["c1","c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:34:56.467Z","link_status":"ok","quote_status":"unverified","prev":"c28d3aeb6e86801e836d5e64398b3dcee54ddda87129b41f4565966e879cb8c8","hash":"d50bcc3dac8e40f8937010ebbffc54447f6757eb56559437a005ed504fee3a33"},{"id":"s22","type":"other","url":"https://www.innerbody.com/pinealon","title":"Pinealon Peptide | Benefits, Safety & Buying Advice [2026]","quote":"These include a trial involving 72 people with traumatic brain injury who exhibited improved memory and cognitive performance after Pinealon administration.","summary":"Reviews human and animal evidence.","claim_ids":["c1","c3","c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:34:56.467Z","link_status":"ok","quote_status":"unverified","prev":"d50bcc3dac8e40f8937010ebbffc54447f6757eb56559437a005ed504fee3a33","hash":"dc931de3135105d909ee8333a9213c614c72ed3d0ece56a89d766b0304a7a9f7"},{"id":"s27","type":"pubmed","url":"https://link.springer.com/article/10.1134/S181971242003006X","title":"Effect of Pinealon on Learning and Expression of NMDA Receptor Subunit Genes in the Hippocampus of Rats with Experimental Diabetes","quote":"The most positive effect on the maintenance of the developed skill during streptozotocin-induced diabetes was observed after pinealon administration at a dose of 100 ng/kg.","summary":"Rat diabetes model study on learning and NMDA genes.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:34:56.467Z","link_status":"ok","quote_status":"verified","prev":"dc931de3135105d909ee8333a9213c614c72ed3d0ece56a89d766b0304a7a9f7","hash":"f25abd8700d14cdef7630cd753acddbeff5a7653416fa2f5a30b2f2f44c2060f"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T01:35:00.055Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"Pinealon for Diabetic Neuropathy: Evidence Review","register":"source_ledger","body":"## What's breaking down if you have Diabetic neuropathy\n\nDiabetic neuropathy involves progressive damage to peripheral nerves. High blood sugar over time drives oxidative stress and inflammation that outpace the body's natural repair processes in nerve tissue. This leads to degeneration of axons and myelin sheaths. The result is sensory loss, pain, or autonomic issues depending on which nerves are affected. The core issue is repair lagging behind breakdown rather than simple symptom masking.\n\n## Why Pinealon might help you\n\n1. You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\n2. **Therefore for you:** If that layer is part of your problem, Pinealon is discussed because it targets repair (tissue) — not because it masks pain.\n\nPinealon is a tripeptide studied in models of neural stress. In the neural / pineal layer, research explores whether it supports neuron survival and gene expression related to synaptic function. If your diabetic neuropathy includes central or cognitive components tied to diabetes, the discussion centers on potential support for those repair pathways rather than direct pain relief.\n\n## How these fit together\n\nSingle-compound focus. Pinealon maps to the neural / pineal layer. If your condition profile includes a multi-peptide stack, siblings would target other layers listed in the condition profile.\n\n## What the evidence actually shows\n\nNo human trials examine Pinealon specifically for diabetic neuropathy. All direct data come from animal models.\n\nOne rat study induced diabetes with streptozotocin and tested Pinealon on spatial learning and NMDA receptor genes in the hippocampus. Rats given Pinealon at 100 ng/kg showed better retention of a learned skill in the Morris water maze compared with diabetic controls. The study also reported normalization of Grin2a/Grin2b subunit ratios. This is preclinical evidence only; it addresses cognitive effects in diabetic rats, not peripheral nerve conduction or pain. (source s27)\n\nOther Pinealon research involves rat models of hypoxia, prenatal stress, or ischemia. These show reduced reactive oxygen species and fewer necrotic cells in brain tissue. Human data are limited to small trials on traumatic brain injury or age-related cognitive decline, none involving diabetes or neuropathy. (sources s18, s20, s22)\n\n## What scientists say\n\nRussian research groups have published on Pinealon as a bioregulator peptide. Reviews note its effects on gene expression and oxidative stress markers in cell and animal models. No large-scale Western clinical trials exist for neuropathy applications. Scientists classify current findings as preliminary mechanistic work.\n\n## What people say on Reddit\n\nAnecdotal reports on Reddit discuss Pinealon in cognitive or anti-aging contexts. No threads specifically link it to diabetic neuropathy symptoms or outcomes. Users note subtle effects on focus or sleep; these remain unverified personal accounts.\n\n## What people say on X\n\nPosts on X mentioning Pinealon focus on general neuroprotection or peptide research summaries. No user reports detail diabetic neuropathy experiences. Mentions stay at the level of sharing study abstracts.\n\n## What we do not know\n\nHuman efficacy, optimal use, long-term effects, and direct impact on peripheral nerve structure or function in diabetic neuropathy remain unknown. No data compare Pinealon to standard care or placebo in this population. Translation from rat diabetes models to human neuropathy is unproven.\n\n## Safety and limits\n\nPinealon appears well tolerated in the small published human studies, with no major adverse events reported. As with any research compound lacking large safety databases, individual responses vary. This article presents evidence tiers only and does not constitute guidance.","claims":[{"id":"c1","text":"No human trials examine Pinealon specifically for diabetic neuropathy.","section":"What the evidence actually shows","tier":"human","source_ids":["s19","s21","s22"],"source_status":"sourced","why_material":"Establishes absence of direct clinical data for the target condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:34:57.572Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"In streptozotocin-induced diabetic rats, Pinealon at 100 ng/kg improved retention of a spatial learning skill and normalized hippocampal NMDA receptor subunit ratios.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s27"],"source_status":"sourced","why_material":"Only direct animal study linking Pinealon to diabetes models; addresses cognition, not peripheral neuropathy.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:34:57.572Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Pinealon reduces reactive oxygen species accumulation and necrotic cell count in rat brain models of hypoxia and ischemia.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s18","s20"],"source_status":"sourced","why_material":"Supports mechanistic discussion of neuroprotection under oxidative stress.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:34:57.572Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Small human trials of Pinealon report improvements in memory and cognition after traumatic brain injury or in age-related decline.","section":"What the evidence actually shows","tier":"human","source_ids":["s21","s22"],"source_status":"sourced","why_material":"Documents available human evidence base, none in diabetic neuropathy.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:34:57.572Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s18","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3342713/","title":"Pinealon protects the rat offspring from prenatal hyperhomocysteinemia","quote":"Using pinealon (Glu-Asp-Arg) under these conditions was found to result in the offspring cognitive function being improved significantly.","link_status":"ok","quote_status":"unverified"},{"id":"s19","type":"other","url":"https://superpower.com/guides/pinealon","title":"Pinealon (EDR): A Khavinson-Group Tripeptide in Research","quote":"Pinealon has no FDA approval, no completed Phase 1 human safety study.","link_status":"ok","quote_status":"unverified"},{"id":"s20","type":"other","url":"https://biotechpeptides.com/2024/11/08/pinealon-peptide-implications-for-neuroprotection-cellular-aging-mechanisms/","title":"Pinealon Peptide: Implications for Neuroprotection & Cellular Aging Mechanisms","quote":"Preliminary studies on Pinealon’s potential cellular impacts, particularly in ischemic stroke models in rats, suggest it may influence key cytokine signaling pathways that regulate caspase-3 enzyme levels.","link_status":"ok","quote_status":"verified"},{"id":"s21","type":"other","url":"https://www.paragonsportsmedicine.com/peptides/pinealon","title":"Pinealon Peptide | Brain & Memory Support","quote":"Cognitive Enhancement Trial (Kryzhanovskaya et al., 2014): 28% improvement in attention and memory tests.","link_status":"ok","quote_status":"unverified"},{"id":"s22","type":"other","url":"https://www.innerbody.com/pinealon","title":"Pinealon Peptide | Benefits, Safety & Buying Advice [2026]","quote":"These include a trial involving 72 people with traumatic brain injury who exhibited improved memory and cognitive performance after Pinealon administration.","link_status":"ok","quote_status":"unverified"},{"id":"s27","type":"pubmed","url":"https://link.springer.com/article/10.1134/S181971242003006X","title":"Effect of Pinealon on Learning and Expression of NMDA Receptor Subunit Genes in the Hippocampus of Rats with Experimental Diabetes","quote":"The most positive effect on the maintenance of the developed skill during streptozotocin-induced diabetes was observed after pinealon administration at a dose of 100 ng/kg.","link_status":"ok","quote_status":"verified"}]},"rationale":"","tokens_in":23710,"tokens_out":2710,"cost":0.0364125,"prev_hash":"genesis","hash":"db5a72e4d992034639328961c2f4d75c89f7e0a791f5176ba1624dcf307aedc5"}],"provenance":[{"ts":"2026-06-30T01:35:00.055Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Pinealon for Diabetic Neuropathy\nSlug: pinealon-diabetic-neuropathy\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Diabetic neuropathy\",\"condition_key\":\"diabetic-neuropathy\",\"primary_peptide\":\"pinealon\",\"peptides_in_scope\":[{\"id\":\"pinealon\",\"name\":\"Pinealon\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Diabetic neuropathy\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"pinealon\",\"name\":\"Pinealon\",\"section_title\":\"Why Pinealon might help you\",\"layer\":\"neural / pineal\",\"steps\":[\"You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, Pinealon is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, Pinealon is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **Pinealon** → neural / pineal\",\"section_headings\":[\"What's breaking down if you have Diabetic neuropathy\",\"Why Pinealon might ","response":"{\n  \"slug\": \"pinealon-diabetic-neuropathy\",\n  \"title\": \"Pinealon for Diabetic Neuropathy: Evidence Review\",\n  \"body\": \"## What's breaking down if you have Diabetic neuropathy\\n\\nDiabetic neuropathy involves progressive damage to peripheral nerves. High blood sugar over time drives oxidative stress and inflammation that outpace the body's natural repair processes in nerve tissue. This leads to degeneration of axons and myelin sheaths. The result is sensory loss, pain, or autonomic issues depending on which nerves are affected. The core issue is repair lagging behind breakdown rather than simple symptom masking.\\n\\n## Why Pinealon might help you\\n\\n1. You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, Pinealon is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nPinealon is a tripeptide studied in models of neural stress. In the neural / pineal layer, research explores whether it supports neuron survival and gene expression related to synaptic function. If your diabetic neuropathy includes central or cognitive components tied to diabetes, the discussion centers on potential support for those repair pathways rather than direct pain relief.\\n\\n## How these fit together\\n\\nSingle-compound focus. Pinealon maps to the neural / pineal layer. If your condition profile includes a multi-peptide stack, siblings would target other layers listed in the condition profile.\\n\\n## What the evidence actually shows\\n\\nNo human trials examine Pinealon specifically for diabetic neuropathy. All direct data come from animal models.\\n\\nOne rat study induced diabetes with streptozotocin and tested Pinealon on spatial learning and NMDA receptor genes in the hippocampus. Rats given Pinealon at 100 ng/kg showed better retention of a learned skill in the Morris water maze compared with diabetic controls. The study also reported normalization of Grin2a/Grin2","tokens_in":23710,"tokens_out":2710,"cost":0,"prev":"genesis","hash":"3e865e1a5b388ab2dda2b7a9b3225a501990b70c51e43b3437a069dcf6292340"},{"ts":"2026-07-17T02:40:51.835Z","model":"owner","action":"voxel_divide","prompt":"","input":"pinealon-diabetic-neuropathy","response":"21 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"3e865e1a5b388ab2dda2b7a9b3225a501990b70c51e43b3437a069dcf6292340","hash":"a57c96af4a7fdc4aaf81973b891eb2b441cb3a9633775436572aee887ecd1bca"}],"energy":{"passes":2,"tokens_in":23710,"tokens_out":2710,"tokens_total":26420,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"a57c96af4a7fdc4aaf81973b891eb2b441cb3a9633775436572aee887ecd1bca"},"posted_at":"2026-06-29T21:32:46.633Z","created_at":"2026-06-29T21:32:46.633Z","updated_at":"2026-07-17T02:40:51.835Z","machine":{"shape":"article.machine/v1","slug":"pinealon-diabetic-neuropathy","kind":"article","read":{"human":"https://miscsubjects.com/a/pinealon-diabetic-neuropathy","json":"https://miscsubjects.com/api/articles/pinealon-diabetic-neuropathy","bundle":"https://miscsubjects.com/api/articles/pinealon-diabetic-neuropathy/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":6,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/pinealon-diabetic-neuropathy/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=pinealon-diabetic-neuropathy","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pinealon-diabetic-neuropathy\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pinealon-diabetic-neuropathy\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/pinealon-diabetic-neuropathy/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"pinealon-diabetic-neuropathy\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/pinealon-diabetic-neuropathy | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/pinealon-diabetic-neuropathy","json":"/api/articles/pinealon-diabetic-neuropathy","markdown":"/api/articles/pinealon-diabetic-neuropathy/bundle?format=markdown","skill":"/api/articles/pinealon-diabetic-neuropathy/skill","topology":"/api/articles/pinealon-diabetic-neuropathy/topology","versions":"/api/articles/pinealon-diabetic-neuropathy/revisions","invocations":"/api/articles/pinealon-diabetic-neuropathy/invocations"},"editorial_review":null,"editorial_audit":{"slug":"pinealon-diabetic-neuropathy","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"f64ffa7243a769bc22b09517122484bceff53b4ecf62b955a1fd9d23dc5a47db"}}}